Indication

Activated phosphoinositide 3-kinase delta syndrome

Activated phosphoinositide 3-kinase delta syndrome is a rare primary immunodeficiency and inborn error of immunity affecting both humoral and cellular components of the immune system. Read more about Activated phosphoinositide 3-kinase delta syndrome

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Activated phosphoinositide 3-kinase delta syndrome therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Activated phosphoinositide 3-kinase delta syndrome preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Activated phosphoinositide 3-kinase delta syndrome.

Activated phosphoinositide 3-kinase delta syndrome is a rare primary immunodeficiency and inborn error of immunity affecting both humoral and cellular components of the immune system.

Caused by autosomal dominant gain-of-function variants in *PIK3CD* or loss-of-function variants in *PIK3R1*, the disorder leads to constitutive hyperactivation of the PI3K-Akt-mTOR signaling pathway in leukocytes.

Pathophysiologically, this results in progressive T- and B-cell dysregulation and lymphopenia, clinically manifesting in childhood as recurrent sinopulmonary and viral infections, bronchiectasis, nonmalignant lymphoproliferation, autoimmunity, and a heightened lifetime risk of lymphoid malignancies.

Personalize your experience

Follow Activated phosphoinositide 3-kinase delta syndrome and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it